Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9480	Companies
185531	Keywords
117919	Articles
99374	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 07/08/2025 at 07:00, 4 months 28 days ago

Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuvenation Conference 2025
Biophytis SA announces participation in ARC 2025 to present results of BIO101 in sarcopenia at the World Aging & Rejuvenation Conference, aiming to strengthen scientific visibility and expand in the longevity market

Sarcopenia Biophytis SA BIO101 Longevity Market ARC 2025
REGULATED PRESS RELEASE

published on 07/08/2025 at 07:00, 4 months 28 days ago

Biophytis au cœur de l’innovation dans la longévité à la conference World Aging & Rejuvenation 2025
Biophytis participe à la 7e conférence mondiale sur le vieillissement et le rajeunissement pour présenter ses résultats sur la sarcopénie et le candidat-médicament BIO101

Biophytis Conference Longévité BIO101 SARA Program
PRESS RELEASE

published on 07/08/2025 at 06:59, 4 months 28 days ago

Biophytis au cœur de l’innovation dans la longévité à la conference World Aging & Rejuvenation 2025
Biophytis annonce sa participation à la conférence World Aging & Rejuvenation 2025 à Vienne. Présentation des résultats du programme SARA sur la sarcopénie avec BIO101

Biophytis Longévité Sarcopénie World Aging & Rejuvenation 2025 SARA
BRIEF

published on 07/07/2025 at 07:05, 4 months 29 days ago

Biophytis Aims to Address Muscle Loss in Obesity Market

Biophytis BIO101 Muscle Preservation GLP-1 Therapies Obesity Market
BRIEF

published on 07/07/2025 at 07:05, 4 months 29 days ago

Biophytis : Avancée sur le Marché de l'Obésité

Biophytis Marché Obésité GLP-1 Masse Musculaire
REGULATED PRESS RELEASE

published on 07/07/2025 at 07:00, 4 months 29 days ago

Obésité : Biophytis Trace sa Voie vers un Marché en Pleine Explosion
BiophyFs SA saisit une opportunité majeure sur le marché de l'obésité en pleine expansion en développant des thérapies pour préserver la masse musculaire. Focusing sur BIO101 et l'importance de la préservation musculaire dans l'obésité

BIO101 Obésité Thérapies Masse Musculaire BiophyFs SA
REGULATED PRESS RELEASE

published on 07/07/2025 at 07:00, 4 months 29 days ago

Obesity: Biophytis Charts Its Course Toward a Booming Market
Biophy.s SA is focusing on developing transformative therapies for obesity, sarcopenia, and longevity by addressing muscle loss with its lead drug BIO101. The company's strategic positioning targets the expanding obesity market

BIO101 Obesity Market Opportunity Muscle Loss Biophy.s SA
BRIEF

published on 07/03/2025 at 07:05, 5 months 2 days ago

Biophytis Showcases Innovations at BIO International 2025

Biophytis Precision Medicine Longevity Sarcopenia Obesity Therapy
BRIEF

published on 07/03/2025 at 07:05, 5 months 2 days ago

Biophytis : Avancées Thérapeutiques Présentées à la BIO International 2025

Biophytis Innovations Santé Thérapies Convention BIO 2025
REGULATED PRESS RELEASE

published on 07/03/2025 at 07:00, 5 months 2 days ago

Biophythis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025
Biophytis highlights innovations in obesity, muscle health, and longevity at BIO International 2025, showcasing therapies targeting key health challenges. Strategic partnerships post-conference aim to accelerate therapies' global impact

Innovations Longevity Obesity Muscle Health Biophy(s

Accesswire

Published on 12/05/2025 at 19:20, 4 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 39 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 4 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 24 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 9 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 25 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 57 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 8 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 32 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 37 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 6 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 6 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 13 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 13 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 25 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE